Literature DB >> 15307423

Seasonality of presentation of imported Plasmodium vivax malaria in Birmingham, UK.

P Venkatesan1, M Dedicoat, J A Innes, C J Ellis.   

Abstract

Residents of the UK returning from northern Pakistan with Plasmodium vivax infection tend to develop symptoms and present to hospital in the summer months, irrespective of the month of return. Thus, infections acquired in the cooler months of November to April appear to have a longer latency before presentation. Experiments suggest that more hypnozoites arise from the liver when ambient temperatures fall, somehow 'programming' parasites within biting mosquitoes.

Entities:  

Mesh:

Year:  2003        PMID: 15307423     DOI: 10.1016/s0035-9203(03)80023-8

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  4 in total

1.  Activation of the hypnozoite: a part of Plasmodium vivax life cycle and survival.

Authors:  Lena Hulden; Larry Hulden
Journal:  Malar J       Date:  2011-04-16       Impact factor: 2.979

2.  Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo.

Authors:  Adeshina I Adekunle; Mykola Pinkevych; Rose McGready; Christine Luxemburger; Lisa J White; François Nosten; Deborah Cromer; Miles P Davenport
Journal:  PLoS Negl Trop Dis       Date:  2015-03-17

3.  Clinical, geographical, and temporal risk factors associated with presentation and outcome of vivax malaria imported into the United Kingdom over 27 years: observational study.

Authors:  Claire Broderick; Behzad Nadjm; Valerie Smith; Marie Blaze; Anna Checkley; Peter L Chiodini; Christopher J M Whitty
Journal:  BMJ       Date:  2015-04-16

4.  Geographical and temporal trends and seasonal relapse in Plasmodium ovale spp. and Plasmodium malariae infections imported to the UK between 1987 and 2015.

Authors:  Laura E B Nabarro; Debbie Nolder; Claire Broderick; Behzad Nadjm; Valerie Smith; Marie Blaze; Anna M Checkley; Peter L Chiodini; Colin J Sutherland; Christopher J M Whitty
Journal:  BMC Med       Date:  2018-11-27       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.